CRO Intel

Dashboard Companies Opportunity Signals Clinical Trials Hiring Intelligence Funding Publications FDA Settings

Company Intelligence

Discover companies with clinical, regulatory and hiring signals
Total Companies

6,643

Company Clinical Trials FDA Signals Hiring Opportunity Confidence Last Seen
Enzon Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Eoc Pharma — — —
60
36% 		7/17/2026 View Intelligence
Eolas Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Eom Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Epiaxis Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Epic Laboratories — — —
60
42% 		7/20/2026 View Intelligence
Epic Medical Supply — — —
60
41% 		7/20/2026 View Intelligence
Epic Pharma — — —
60
42% 		7/20/2026 View Intelligence
Epics Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Epidemiologie Pharmacologie Investigation Clinique Information Medicale Mere Enfant (epicime) — — —
60
36% 		7/17/2026 View Intelligence
Epiendo Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Epigenic Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Epimab Biotherapeutics (suzhou) — — —
60
36% 		7/17/2026 View Intelligence
Epion Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Epiphany Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Epirus Biopharmaceuticals (switzerland) — — —
60
36% 		7/17/2026 View Intelligence
Epitome Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Epix Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Epizon Pharma — — —
60
36% 		7/17/2026 View Intelligence
Equilibre Biopharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Era Organics — — —
60
40% 		7/20/2026 View Intelligence
Erempharma — — —
60
36% 		7/17/2026 View Intelligence
Erimos Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Erno Laszlo — — —
60
40% 		7/20/2026 View Intelligence
Erx Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Erytech Pharma — — —
60
36% 		7/17/2026 View Intelligence
Es Therapeutics Australia — — —
60
36% 		7/17/2026 View Intelligence
Escalier Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Escient Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Esjay Pharma — — —
60
39% 		7/20/2026 View Intelligence
Esp Pharma — — —
60
36% 		7/17/2026 View Intelligence
Esperance Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Esperas Pharma — — —
60
36% 		7/17/2026 View Intelligence
Esperion Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Espero Biopharma — — —
60
36% 		7/17/2026 View Intelligence
Essa Pharma — — —
60
36% 		7/17/2026 View Intelligence
Essa Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Essence — — —
60
42% 		7/20/2026 View Intelligence
Essential Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Essex Pharma — — —
60
36% 		7/17/2026 View Intelligence
Essex Pharma Germany — — —
60
36% 		7/17/2026 View Intelligence
Essity HMS North America — — —
60
40% 		7/20/2026 View Intelligence
Essity Professional Hygiene North America — — —
60
40% 		7/20/2026 View Intelligence
Esteve Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Esteve Pharmaceuticals Sas — — —
60
36% 		7/17/2026 View Intelligence
Estrella Biopharma — — —
60
36% 		7/17/2026 View Intelligence
Etern Biopharma (shanghai) — — —
60
36% 		7/17/2026 View Intelligence
Etern Therapeutics Wuxi — — —
60
36% 		7/17/2026 View Intelligence
Etnova Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Euclises Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Showing 2101 - 2150 of 6,643 companies